{{Rsnum
|rsid=891835
|Chromosome=8
|position=129479506
|Orientation=plus
|GMAF=0.1593
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 3.5 | 31.0 | 65.5
| HCB | 2.9 | 21.2 | 75.9
| JPT | 0.9 | 30.4 | 68.8
| YRI | 0.0 | 2.0 | 98.0
| ASW | 0.0 | 7.0 | 93.0
| CHB | 2.9 | 21.2 | 75.9
| CHD | 1.8 | 24.8 | 73.4
| GIH | 1.0 | 13.9 | 85.1
| LWK | 0.0 | 0.9 | 99.1
| MEX | 3.4 | 32.8 | 63.8
| MKK | 0.0 | 12.8 | 87.2
| TSI | 4.9 | 30.4 | 64.7
| HapMapRevision=28
}}
{{PMID Auto GWAS
|PMID=19578367
|Trait=Glioma
|Title=Genome-wide association study identifies five susceptibility loci for glioma
|RiskAllele=G
|Pval=8E-11
|OR=1.24
|ORtxt=[1.17-1.30]
}}

{{PMID Auto
|PMID=20368557
|Title=Polymorphisms of LIG4, BTBD2, HMGA2, and RTEL1 genes involved in the double-strand break repair pathway predict glioblastoma survival.
|OA=1
}}

{{PMID Auto
|PMID=24870769
|Title=CCDC26 Gene Polymorphism and Glioblastoma Risk in the Han Chinese Population
}}
{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}